Event organized by Informa Markets in India to bring over 2,000 exhibitors & 50,000 industry participants from more than 120 countries under one roof. Organized by Informa Markets in India, the 18th edition of CPHI & PMEC India 2025, South Asia's largest and most influential pharmaceutical industry event, is scheduled
The evolving biosimilar regulations in the United States are poised to create new growth opportunities for Indian pharmaceutical companies, with experts predicting a significant uptick in exports and partnerships in the biopharma segment. The U.S. Food and Drug Administration’s (FDA) streamlined approval pathway for biosimilars, along
In a move to strengthen drug regulation and ensure the availability of safe, high-quality medicines, Uttar Pradesh Chief Minister Yogi Adityanath announced that the state government will double the number of drug inspectors across the state. The decision is aimed at improving the monitoring of
The Government of India has announced the launch of the PRIP (Promoting Research and Innovation in Pharma-MedTech) scheme, inviting proposals from industry players, startups, and research organizations for high-impact projects aimed at strengthening India’s pharmaceutical and medical technology ecosystem. The initiative is designed to accelerate
India’s healthcare stakeholders — including hospitals, diagnostic chains, medical device firms, insurers and pharma groups — have responded positively to the rollout of GST 2.0, saying the tax changes announced under Prime Minister Narendra Modi’s leadership will alleviate cost pressures, expand access, and give a
Anurag University has further strengthened its industry partnerships by signing a Memorandum of Understanding (MoU) with MSN Laboratories Limited, one of India’s leading pharmaceutical companies. The collaboration also marks the announcement of a MSN Labs Bridge Course (2025–26) to MSN employees at Anurag University which
The Government of Goa has joined hands with leading health technology startup Qure.ai and global biopharmaceutical giant AstraZeneca to launch India’s first-ever Innovative Pricing Policy for Lifesaving Therapies, an ambitious step to make breakthrough clinical treatments affordable and accessible for all. This transformative initiative, driven by
Visakhapatnam doctors perform CPR with ECMO - Man accidentally inhaled isobutyl nitrate - Rare, life-saving procedure brings him back from the brink The thought of the heart suddenly stopping is terrifying. But in Visakhapatnam, a man’s heart stopped multiple times. Luckily, being at the right hospital at the
‘Heal in Rajasthan Policy 2025’ positioned to transform the state into a medical and wellness tourism hub In a landmark move, the Rajasthan state cabinet, under Chief Minister Bhajan Lal Sharma, has formally approved the Heal in Rajasthan Policy 2025, designed to establish Rajasthan as a
Rising Alarms Over Substandard Drugs NITI Aayog has initiated a review following alarming data from the Central Drugs Standard Control Organisation (CDSCO), which revealed that multiple micro, small, and medium enterprise (MSME) pharmaceutical firms in India are producing substandard medications, prompting calls for strengthened oversight and
